Back to Search Start Over

Moving East: the Euro-Lupus Nephritis regimen in Asia.

Authors :
UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales
UCL - (SLuc) Service de rhumatologie
Houssiau, Frédéric
UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales
UCL - (SLuc) Service de rhumatologie
Houssiau, Frédéric
Source :
Kidney International, Vol. 89, no. 1, p. 25-27 (2016)
Publication Year :
2016

Abstract

Treatment of lupus nephritis is more evidenced-based than ever. Yet many areas of uncertainty persist. The article by Rathi et al. brings a piece to the puzzle by comparing, in a group of Indian patients, the Euro-Lupus low-dose i.v. cyclophosphamide regimen with mycophenolate mofetil. Although some caveats must be raised, the results suggest that, after crossing the Atlantic, the Euro-Lupus regimen may well be moving East.

Details

Database :
OAIster
Journal :
Kidney International, Vol. 89, no. 1, p. 25-27 (2016)
Notes :
Ndonga
Publication Type :
Electronic Resource
Accession number :
edsoai.on1130469005
Document Type :
Electronic Resource